2 min read Health Gilead Acquires Arcellx for $7.8 Billion to Enhance CAR-T Therapy Editorial 23 February, 2026 Gilead Sciences has announced its acquisition of Arcellx, a partner in its cell therapy...Read More
2 min read Science Navigating Therapy Options for Relapsed Multiple Myeloma Patients Editorial 25 July, 2025 Recent advancements in the treatment of relapsed multiple myeloma have introduced a range of...Read More
